M.P. Freda

860 total citations
11 papers, 616 citations indexed

About

M.P. Freda is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M.P. Freda has authored 11 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M.P. Freda's work include Muscle Physiology and Disorders (10 papers), Genetic Neurodegenerative Diseases (9 papers) and Cardiomyopathy and Myosin Studies (3 papers). M.P. Freda is often cited by papers focused on Muscle Physiology and Disorders (10 papers), Genetic Neurodegenerative Diseases (9 papers) and Cardiomyopathy and Myosin Studies (3 papers). M.P. Freda collaborates with scholars based in Italy, United States and Netherlands. M.P. Freda's co-authors include C. Angelini, Eric P. Hoffman, David Duggan, Flávia Martinello, Paola Melacini, Sergio Dalla Volta, Marta Miorin, Gabriele Siciliano, Elena Pegoraro and Francesco Mari and has published in prestigious journals such as Circulation, Brain and Neurology.

In The Last Decade

M.P. Freda

11 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.P. Freda Italy 10 559 280 157 87 77 11 616
Lidia González‐Quereda Spain 13 476 0.9× 156 0.6× 119 0.8× 109 1.3× 58 0.8× 35 540
Misako Kaido Japan 13 369 0.7× 109 0.4× 105 0.7× 56 0.6× 39 0.5× 31 500
Lindsay M. Wallace United States 12 573 1.0× 126 0.5× 100 0.6× 147 1.7× 23 0.3× 21 665
R. Mein United Kingdom 12 617 1.1× 171 0.6× 99 0.6× 152 1.7× 75 1.0× 23 703
Leigh B. Waddell Australia 14 536 1.0× 317 1.1× 122 0.8× 217 2.5× 89 1.2× 20 648
F. Tomé France 11 507 0.9× 99 0.4× 85 0.5× 82 0.9× 59 0.8× 15 584
Laura Jarre Italy 12 291 0.5× 58 0.2× 102 0.6× 31 0.4× 46 0.6× 18 385
Francesco Laschena Italy 12 419 0.7× 192 0.7× 172 1.1× 104 1.2× 20 0.3× 18 534
Monica Traverso Italy 13 348 0.6× 61 0.2× 66 0.4× 30 0.3× 81 1.1× 32 488
Bharati Shah United States 8 418 0.7× 64 0.2× 61 0.4× 54 0.6× 66 0.9× 8 490

Countries citing papers authored by M.P. Freda

Since Specialization
Citations

This map shows the geographic impact of M.P. Freda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.P. Freda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.P. Freda more than expected).

Fields of papers citing papers by M.P. Freda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.P. Freda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.P. Freda. The network helps show where M.P. Freda may publish in the future.

Co-authorship network of co-authors of M.P. Freda

This figure shows the co-authorship network connecting the top 25 collaborators of M.P. Freda. A scholar is included among the top collaborators of M.P. Freda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.P. Freda. M.P. Freda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Trevisan, Carlo P., Ebe Pastorello, Simone Tonello, et al.. (2001). Ataxia and Congenital Muscular Dystrophy: the follow-up of a new specific phenotype. Brain and Development. 23(2). 108–114. 4 indexed citations
2.
Vergani, Lodovica, Maria Barile, C. Angelini, et al.. (1999). Riboflavin therapy. Brain. 122(12). 2401–2411. 69 indexed citations
3.
Melacini, Paola, David Duggan, M.P. Freda, et al.. (1999). Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle & Nerve. 22(4). 473–479. 94 indexed citations
4.
Angelini, C., et al.. (1999). The clinical spectrum of sarcoglycanopathies. Neurology. 52(1). 176–176. 67 indexed citations
5.
Angelini, C., Francesco Mari, E. Menegazzo, et al.. (1998). Homozygous ?-sarcoglycan mutation in two siblings: One asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient. Muscle & Nerve. 21(6). 769–775. 51 indexed citations
6.
Duggan, David, Maria Luisa Mostacciuolo, Flávia Martinello, et al.. (1997). Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations.. Journal of Medical Genetics. 34(12). 973–977. 66 indexed citations
7.
Mari, Francesco, M.P. Freda, Libero Vitiello, et al.. (1996). Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: Threshold effect for deletion size?. Muscle & Nerve. 19(9). 1154–1160. 36 indexed citations
8.
Angelini, C., M.P. Freda, Flávia Martinello, et al.. (1996). Prognostic factors in mild dystrophinopathies. Journal of the Neurological Sciences. 142(1-2). 70–78. 38 indexed citations
9.
Melacini, Paola, G Danieli, C Villanova, et al.. (1996). Myocardial Involvement Is Very Frequent Among Patients Affected With Subclinical Becker's Muscular Dystrophy. Circulation. 94(12). 3168–3175. 139 indexed citations
10.
Siciliano, Gabriele, C. Angelini, Marta Miorin, et al.. (1994). Prevalent cardiac involvement in dystrophin Becker type mutation. Neuromuscular Disorders. 4(4). 381–386. 12 indexed citations
11.
Angelini, C., et al.. (1994). Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: Characterization of sub-clinical phenotypes. Neuromuscular Disorders. 4(4). 349–358. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026